Sebelius Touts Safety Of New H1N1 Vaccine
Posted on: Wednesday, 7 October 2009, 13:16 CDT
In an effort to ease public fears about the new H1N1 flu vaccine, Health and Human Services Secretary Kathleen Sebelius announced Wednesday that the vaccine was the safest way to avoid the virus.
“We know it's safe and secure,” Sebelius said during appearances on morning talk shows.
"The vaccination is being made exactly the same way seasonal flu vaccine has been made year in and year out," she told Good Morning America on Tuesday.
"The adverse effects are minimal compared to what can happen when you get the flu."
Sebelius added that young children are vulnerable to the H1N1 flu because they have no immunity to the virus.
What’s more, children are more likely to spread the virus to others around them, she said.
"We strongly urge parents to take precautionary steps, the flu kills every year, people get seriously ill, and we've got a great vaccine to deal with it," said Sebelius.
"We now have over 600 deaths reported. Taking the chance that you or your roommate or your child may be one of those rare but serious cases may have underlying impact may expose someone else."
Additionally, she noted that only about 40 percent of US healthcare workers reported they would be getting seasonal flu vaccines.
“I'm hopeful that healthcare workers not only take the seasonal but get at the front of the line for H1N1,” she told CNN.
---
On the Net:
Source: RedOrbit Staff & Wire Reports
Related Articles
- Concentra Supports National Influenza Vaccination Week, Offers H1N1 Vaccines
- U.S. Department of Health and Human Services and the Ad Council Launch New Nationwide PSA Campaign Urging Vaccination against the H1N1 Flu Virus
- Tips To Enjoy a Flu-Free Holiday Season
- FDA Approves Vaccines for 2009 H1N1 Influenza Virus
- Integrated BioPharma's Plant-Produced Flu Subunit Vaccines Provide Protection in Preclinical Studies
- Single Injection of Vical's Avian Flu DNA Vaccine Provides 100% Protection in Ferrets
- New Bird Flu Cases Fuel Fears Virus May Spread Further in Romania
- Sinovac Biotech Ltd. Begins Pandemic Flu (H5N1) Vaccine Clinical Trials
- Health Department Ready With Flu Shots: Vaccine to Be Available to High Risk Groups Until Oct. 24 When It Will Be Offered to General Public
- Genomes of more than 200 human flu strains reveal a dynamic virus
User Comments (0)


RSS Feeds